Current:Home > BackNorth Dakota regulators deny siting permit for Summit carbon dioxide pipeline-LoTradeCoin
North Dakota regulators deny siting permit for Summit carbon dioxide pipeline
View Date:2024-12-23 23:33:03
BISMARCK, N.D. (AP) — North Dakota regulators denied a siting permit Friday for a proposed carbon dioxide pipeline through five states.
The North Dakota Public Service Commission denied the permit for the Summit Carbon Solutions Midwest Carbon Express pipeline, which planned a 320-mile route through North Dakota. Summit proposed the pipeline to capture carbon dioxide from more than 30 ethanol plants in Iowa, Minnesota, Nebraska, North Dakota and South Dakota, and to store it deep underground in North Dakota.
In a statement, Summit said it “respects the decision by the North Dakota Public Service Commission, and we will revisit our proposal and reapply for our permit. We’re committed to understanding and incorporating the considerations outlined in the decision. We are confident that our project supports state policies designed to boost key economic sectors: agriculture, ethanol, and energy.”
The project has raised landowner concerns of eminent domain, or the taking of private land for the pipeline, and potential dangers of a pipeline break.
The company has “legal options” it can take, commission spokesperson Stacy Eberl said. The regulators do not have jurisdiction over injection sites, she said. Summit proposed an underground injection site in central North Dakota.
The Public Service Commission held public hearings throughout North Dakota this year, during which landowners expressed many concerns, including about eminent domain, safety and requests for reroutes on their property.
“The Commission felt that Summit has not taken steps to address outstanding legitimate impacts and concerns expressed by landowners or demonstrated why a reroute is not feasible,” the regulators said in a statement. “The Commission also requested additional information on a number of issues that came up during the hearings. Summit either did not adequately address these requests or did not tender a witness to answer the questions.”
veryGood! (776)
Related
- Oregon's Dan Lanning, Indiana's Curt Cignetti pocket big bonuses after Week 11 wins
- Acid poured on slides at Massachusetts playground; children suffer burns
- In Baidoa, Somalis live at the epicenter of drought, hunger and conflict
- Updated COVID booster shots reduce the risk of hospitalization, CDC reports
- Travis Kelce's and Patrick Mahomes' Kansas City Houses Burglarized
- Rob Lowe Celebrates 33 Years of Sobriety With Message on His Recovery Journey
- States Vowed to Uphold America’s Climate Pledge. Are They Succeeding?
- South Africa Unveils Plans for “World’s Biggest” Solar Power Plant
- Bill on school bathroom use by transgender students clears Ohio Legislature, heads to governor
- I'm Crying Cuz... I'm Human
Ranking
- Jared Goff stats: Lions QB throws career-high 5 INTs in SNF win over Texans
- Inside Blake Lively's Family World With Ryan Reynolds, 4 Kids and Countless Wisecracks
- Get $98 Worth of Peter Thomas Roth Skincare Products for Just $49
- 4 shot, 2 critically injured, in the midst of funeral procession near Chicago
- Trump's election has women swearing off sex with men. It's called the 4B movement.
- When Protest Becomes Sacrament: Grady Sisters Heed a Higher Call
- Fears of a 'dark COVID winter' in rural China grow as the holiday rush begins
- Blac Chyna Reflects on Her Past Crazy Face Months After Removing Fillers
Recommendation
-
Are Dancing with the Stars’ Jenn Tran and Sasha Farber Living Together? She Says…
-
Ashley Graham Shares the Beauty Must-Have She Uses Morning, Noon and Night
-
Kim Zolciak Spotted Without Wedding Ring Amid Kroy Biermann Divorce
-
Today’s Climate: September 7, 2010
-
Review: 'Emilia Pérez' is the most wildly original film you'll see in 2024
-
Climate Costs Rise as Amazon, Retailers Compete on Fast Delivery
-
This is what displaced Somalians want you to know about their humanitarian crisis
-
CRISPR gene-editing may boost cancer immunotherapy, new study finds